TB CAB statement on M72/AS01E TB vaccine candidate development

Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate

The Global TB Community Advisory Board (TB CAB) submitted a statement to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate convened by the World Health Organization on April 5, 2019.

"Advancing TB research is an urgent scientific, public health, and human rights priority for our communities, and the development of a new TB vaccine is a critical piece of the TB research agenda."

To download the statement, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By TB CAB, Treatment Action Group

Published: April 4, 2019, 3:21 p.m.

Last updated: April 4, 2019, 3:27 p.m.

Print Share